Ịgba ọgwụ mgbochi ọrịa: 80%-97% nke Africa nọ na nsogbu na njem nlegharị anya

1. Africa na-akwado maka ọgwụ mgbochi COVID-19
2. Ọgwụ mgbochi AstraZeneca/Oxford AZD1222 na-apụta n'Africa
3. Nke mbụ 90 nde doses mana naanị 3% nke ndị Africa
4. Naanị 20% nke Africa na-atụ anya ịgba ọgwụ mgbochi na 2021

WHO weputara ya dị ka ozi ọma, n'eziokwu, Africa yiri ka ọ na-enweta obere osisi ma a bịa n'ị nweta ọgwụ mgbochi Coronavirus.

Onye na-ekwuchitere Ndị njem nlegharị anya Africad chere na nke a bụ akụkọ jọgburu onwe ya maka kọntinent na ọbụna akụkọ ka njọ maka akụ na ụba njem nlegharị anya n'afọ a.

Matshidiso Moeti, onye isi ngalaba WHO na mpaghara Afrịka, mere ka ọ pụta ìhè na mbupụ a bụ “nzọụkwụ mbụ dị mkpa” iji hụ na mba nwere nweta ọgwụ mgbochi. 

“Afrịka elelela mpaghara ndị ọzọ na-amalite mkpọsa ịgba ọgwụ mgbochi COVID-19 site n'akụkụ akụkụ ogologo oge. Mwepụta a na-eme atụmatụ bụ nzọụkwụ mbụ dị oke mkpa iji hụ na kọntinent ahụ na-enweta ọgwụ mgbochi n'ụzọ ziri ezi", Dr. Moeti kwuru. 

Mwepụta nke ọgwụ mgbochi AstraZeneca/Oxford AZD1222 dị n'okpuru ọgwụ mgbochi edepụtara maka ojiji mberede nke WHO, nke na-enyocha ọgwụ mgbochi ugbu a na a na-atụ anya nsonaazụ ya n'oge adịghị anya, dịka ụlọ ọrụ ahụ siri kwuo. 

N'ime ọnụ ọgụgụ na-arị elu maka ọgwụ mgbochi COVID-19, mbupu ikpeazụ ga-adabere n'ikike mmepụta nke ndị na-emepụta ọgwụ mgbochi na ịdị njikere nke mba, WHO gbakwụnyere, na-ekwupụta na mba ndị na-anabata ya kwesịrị ịnyefe mbupụ mba na atụmatụ ịgba ọgwụ mgbochi iji nweta ọgwụ mgbochi sitere na COVAX. ihe owuwu. 

Usoro ọgwụ nde 90 mbụ ga-akwado mba iri atọ pasentị nke ndị Africa nwere mkpa nchekwa, gụnyere ndị ọrụ ahụike na ndị otu ndị ọzọ adịghị ike na ọkara mbụ nke 3. 

Ka ikike mmepụta na-abawanye na ọtụtụ ọgwụ mgbochi na-adị, ebumnuche bụ ịgba ọgwụ opekata mpe pasentị 20 nke ndị Africa site n'inye ihe ruru nde 600 na njedebe nke 2021. 

'gbalite njikere' 

Dr. Moeti kwukwara na ọkwa a na-enye mba Africa ohere imezi atụmatụ ha maka ịgba ọgwụ mgbochi COVID-19 ma kpọkuo mba ndị ahụ ka ha mechaa atụmatụ ịgba ọgwụ mgbochi ọrịa. 

"Anyị na-agba ndị mba Africa ume ka ha kwalite njikere ma mechaa atụmatụ ibunye ọgwụ mgbochi mba ha. Usoro nhazi, sistemu yinye oyi na atụmatụ nkesa kwesịrị ịdị n'ọnọdụ iji hụ na agbapụrụ ọgwụ mgbochi n'enweghị nsogbu site n'ọdụ ụgbọ mmiri mbata na mbufe, "ka o kwukwara. 

"Anyị enweghị ike ịla n'iyi otu dose." 

Usoro ndị ọzọ 

Iji kwado mbọ COVAX, African Union enwetala ọgwụ mgbochi nde 670 maka kọntinent ahụ nke a ga-ekesa na 2021 na 2022 ka mba na-enweta ego zuru oke, dịka WHO siri kwuo. 

Na mgbakwunye, ihe dị ka ọgwụ 320,000 nke ọgwụ mgbochi Pfizer-BioNTech, nke anatalarị WHO Emergency User, ka ekenyela mba anọ dị n'Africa - Cabo Verde, Rwanda, South Africa, na Tunisia - ndị nwere ikike ịchekwa ma kesaa dose na mwepu. 70 Celsius, ụlọ ọrụ ahụ kwuru. 

Ụlọ ọrụ COVAX 

Ụlọ ọrụ COVAX Global Vaccines Facility bụ ogidi ọgwụ mgbochi nke ACT-Accelerator, atụmatụ ewepụtara na Eprel 2020 iji mee ka mmepe ọgwụ dị ngwa iji gwọọ COVID-19 wee mee ka ndị mmadụ nweta ya n'ebe niile. 

Ebumnuche zuru ụwa ọnụ bụ WHO na-eduzi; Gavi the Vaccine Alliance; na Njikọ aka maka Innovations Nkwadebe Ọrịa (CEPI). Ọ na-arụ ọrụ iji hụ na ọtụtụ mba dị ka enwere ike imekọ ihe ọnụ na mmepe ọdọ mmiri, ịzụ ahịa na ikenye ọgwụ mgbochi COVID-19 ọ bụla. 

Isi mmalite UN News Center